BioCardia, Inc. Operating Lease, Liability, Noncurrent
BioCardia, Inc. (BCDA) had Operating Lease, Liability, Noncurrent of $0 as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Noncurrent $0.00.
- 2026-03-31: Operating Lease, Liability, Noncurrent $0.00.
- 2025-12-31: Operating Lease, Liability, Noncurrent $86.00K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $211.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 |
| 2025-12-31 | $86.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $211.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $333.00K 10-Q/A · filed 2025-10-29 |
| 2025-03-31 | $452.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $566.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $674.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $780.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $883.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $982.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $1.08M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.14M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.23M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.32M 10-K · filed 2024-03-27 |
| 2022-09-30 | $1.40M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.48M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.56M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.63M 10-K · filed 2023-03-29 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
| 2020-09-30 | $161.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $316.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $468.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $614.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | $752.00K 10-Q · filed 2019-11-19 |
| 2019-06-30 | $886.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.02M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |